Hepatology

Paediatric autoimmune hepatitis incidence in Denmark has surged, yet most children maintain liver function with standard immunosuppressive therapy.

Underreported alcohol use masks alcohol-related liver disease, increasing misclassification and obscuring true mortality rates.

Telemedicine nutrition care reduces MASLD and liver disease risk in adults with type 2 diabetes and obesity, showing promise for lifestyle-first interventions.

In a northern Mexico cohort, MASLD now accounts for the largest share of chronic liver disease and cirrhosis cases.

Normothermic machine perfusion allows clinicians to assess high-risk livers from donors after circulatory or brain death before transplantation.

Sudan faces an outbreak of acute hepatitis among displaced populations, with severe liver complications in vulnerable communities.

Obesity drives liver disease progression, with new therapies and weight-loss strategies offering hope for improved outcomes in MASLD and MASH.

Advanced chronic liver disease is driven by portal hypertension. Explore how beta-blockers like carvedilol may help manage risk and delay decompensation.